Phase 3, Multicenter Open-Label study to investigate the efficacy of elbasvir and grazoprevir fixed-dose combination for eight weeks in treatment-naïve, HCV GT1b-infected patients, with non-severe fibrosis
| Image |  |
|---|---|
| Description | scientific article published on 08 May 2020 |
| Author/s |
author: Bruno Pereira Brigitte Chanteranne Didier Samuel Vincent Di Martino Stanislas Pol Tarik Asselah |
| Publication date | May 8, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |